← Browse by Condition
Medical Condition

myocarditis

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for myocarditis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — myocarditis Clinical Trials

How many clinical trials are currently recruiting for myocarditis?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for myocarditis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for myocarditis?
myocarditis research spans Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a myocarditis clinical trial?
Eligibility criteria for myocarditis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Phase 4
1
Top Sponsors
Niguarda Hospital 1 trial
Azienda Ospedaliero, Universitaria Ospedali Riuniti 1 trial
Second Affiliated Hospital, Zhejiang University, School of Medicine 1 trial
Samsung Medical Center 1 trial

Recruiting Clinical Trials

NCT06158698 Phase 3
Recruiting
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
Enrollment
80 pts
Location
Italy
Sponsor
Niguarda Hospital
View Trial →
NCT07086144
Recruiting
Efficacy of a Myocardial Panel in the Management and Treatment of Pediatric Myocarditis
Enrollment
30 pts
Location
Italy
Sponsor
Azienda Ospedaliero, Universit...
View Trial →
NCT05718128 Phase 4
Recruiting
Clinical Study of Endocardial Myocardial Biopsy
Enrollment
100 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
View Trial →
NCT07482865
Recruiting
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Enrollment
500 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →

Related Conditions

cardiomyopathies (2) heart failure (2) inflammatory cardiomyopathy (1) ventricular arrythmia (1) cardiac tumor (1) endocardiomyocardial biopsy (1) cardiogenic shock (1) acute myocardial infarction of inferior wall (1) congestive heart failure (1) acute limb ischemia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology